HomeREGULATORY
REGULATORY

MHLW Health Policy Chief Questions Volume-Focused Sales Strategies, Urges Drug Makers to Shift to Healthy Lifespan Extension
(Mar.19.2018)

Toshihiko Takeda, director-general, Health Policy Bureau
While pharmaceutical makers work to make up for drug price cuts by ramping up prescriptions through intensive sales activities, the Japanese government is casting doubt on this business model as its policy focus shifts from disease prevention to the extension of healthy lifespans, a senior health ministry official says ...
(LOG IN FOR FULL STORY)